Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | iSTOXX® FactSet Breakthrough Healthcare |
| Investment focus | Equity, World, Health Care, Social/Environmental |
| Fund size | EUR 864 m |
| Total expense ratio | 0.40% p.a. |
| Replication | Physical (Optimized sampling) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | Yes |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 14.97% |
| Inception/ Listing Date | 8 September 2016 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | iShares |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Fund Services (Ireland) Limited |
| Investment Advisor | |
| Custodian Bank | State Street Custodial Services (Ireland) Limited |
| Revision Company | Deloitte |
| Fiscal Year End | 31 May |
| Swiss representative | BlackRock Asset Management Schweiz AG |
| Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
| Securities lending | Yes |
| Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
| Moderna, Inc. | 2.30% |
| Exact Sciences | 2.24% |
| Johnson & Johnson | 2.20% |
| UCB SA | 2.20% |
| Merck & Co., Inc. | 2.07% |
| Illumina, Inc. | 2.05% |
| GSK Plc | 2.03% |
| Celltrion, Inc. | 2.01% |
| Novartis AG | 1.97% |
| Biogen, Inc. | 1.96% |
| United States | 63.10% |
| Switzerland | 5.91% |
| South Korea | 4.89% |
| Japan | 3.88% |
| Other | 22.22% |
| Health Care | 91.58% |
| Technology | 1.55% |
| Other | 6.87% |
| YTD | -2.09% |
| 1 month | -2.47% |
| 3 months | -6.83% |
| 6 months | +3.16% |
| 1 year | +20.97% |
| 3 years | +10.29% |
| 5 years | -9.96% |
| Since inception (MAX) | +68.16% |
| 2025 | +4.79% |
| 2024 | +7.98% |
| 2023 | -1.46% |
| 2022 | -18.99% |
| Volatility 1 year | 14.97% |
| Volatility 3 years | 14.96% |
| Volatility 5 years | 17.91% |
| Return per risk 1 year | 1.40 |
| Return per risk 3 years | 0.22 |
| Return per risk 5 years | -0.12 |
| Maximum drawdown 1 year | -10.43% |
| Maximum drawdown 3 years | -21.98% |
| Maximum drawdown 5 years | -36.96% |
| Maximum drawdown since inception | -38.72% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | 2B78 | - - | - - | - |
| Stuttgart Stock Exchange | EUR | 2B78 | - - | - - | - |
| Bolsa Mexicana de Valores | MXN | - | HEALN MM | HEALN.MX | |
| Borsa Italiana | EUR | HEAL | HEAL IM INAVHEAE | HEAL.MI | |
| Euronext Amsterdam | EUR | HEAL | HEAL NA | ||
| London Stock Exchange | GBX | DRDR | DRDR LN | DRDR.L | |
| London Stock Exchange | USD | HEAL | HEAL LN INAVHEAU | HEAL.L 0O64INAV.DE | |
| London Stock Exchange | GBP | - | DRDR LN INAVHEAG | DRDR.L 0O62INAV.DE | |
| SIX Swiss Exchange | USD | HEAL | HEAL SE INAVHEAU | HEAL.S 0O64INAV.DE | |
| XETRA | EUR | 2B78 | 2B78 GY INAVHEAE | 2B78.DE 0O60INAV.DE |